Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey R Infante, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Cancer Center
Scottsdale, Arizona, United States
- Premiere Oncology of Arizona
Scottsdale, Arizona, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Lsu Health Sciences Center
Shreveport, Louisiana, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Ut Health Science Center
San Antonio, Texas, United States
- Northwest Medical Specialties
Tacoma, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Jul 2013
- Completion
- 31 Mar 2014
- Last update posted
- 7 May 2015
- Registered enrollment
- 71
- Registry id
- NCT00743379
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.